Natural clearance of hepatitis C virus in hemophilia patients

Medicina

Volumn 44, Issue 1, 2008, Pages 15-21

  Simanis, Raimonds ^a   Lejniece, Sandra ^a   Sochnevs, Arturs ^a   Eglite, Jelena ^a   Chernevska, Gunta ^b   Kovalova, Zhanna ^a   Gardovska, Dace ^a   Jeruma, Agita ^a   Kuse, Velga ^a   Viksna, Ludmila ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b Children's University Hospital Child Psychiatry Clinic   (Latvia)

Author keywords

Hemophilia; Hepatitis C virus; Human leukocyte antigen; Natural clearance

Indexed keywords

HLA ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGE; ARTICLE; CHI SQUARE DISTRIBUTION; CHILD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENETICS; GENOTYPE; HEMOPHILIA A; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LATVIA; LITHUANIA; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; STATISTICAL ANALYSIS; UNITED STATES; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, MHC CLASS II; GENOTYPE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HLA ANTIGENS; HUMANS; LATVIA; LITHUANIA; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; UNITED STATES;

EID: 40949101416     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44010003     Document Type: Article

References (30)

1. Foster GR, Goldin RD. Management of chronic viral hepatitis. 2nd ed. Taylor & Francis Group; 2005.
2. Viksna L. Virushepatits C - norise, ārstēšana, prognoze, profilakse. (Viral hepatitis C - course, treatment, prognosis, prophylaxis.) Nacionālais apgāds; 2003.
3. Blanchette VS, Vorstman E, Shore A, Wang E, Petric M, Jett BW, et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991;78(2):285-9.
4. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000;47:845-51.
5. Neumann-Haefelin C, Blum HE, Chisari FV, Thimme R. T cell response in hepatitis C virus infection. J Clin Virol 2005;32:75-85.
6. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003;125:80-8.
7. Fried MW, Kroner BL, Preiss LR, Wilhelmsen K, Goedert JJ. Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance. Gastroenterology 2006;131:757-65.
8. Sun J, Li K, Shata MT, Chan TS. The immunologic basis for hepatitis C infection. Curr Opin Gastroenterol 2004;20:598-602.
9. Aberle J, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, et al. Prospective study of viral clearance and CD4+ T cell response in acute hepatitis C primary infection and reinfection. J Clin Virol 2006;36:24-31.
10. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004;5:237-45.
11. Silonova G, Graudiņa Ž. Virushepatits C. (Viral hepatitis C.) Latvijas Ārsts 1994;1:42-3.
12. Wawrzynowicz-Syczewska M, Underhill JA, Clare MA, Boron-Kaczmarska A, McFarlane IG, Donaldson PT. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 2000;20(3):234-9.
13. Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 1999;179:1004-6.
14. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184:16-21.
15. Mangia A, Gentile R, Cascavilla I, Margaglione M, Villani MR, Stella F, et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 1999;30:984-9.
16. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of the MHC Class II genotype on outcome of infection with hepatitis C. The Lancet 1999;354:2119-24.
17. Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998;28:1-7.
18. Nowakowska B, Kacprzak-Bergman I. Zwiazek antygenów zgodności tkankowej HLA z zakazeniem wirusem zapalenia watroby typu C (HCV). (Association between HLA antigens and hepatitis C virus (HCV) infection.) Postepy Hig Med Dosw (Online) 2004;(58):458-62.
19. Donaldson PT. Genetics of liver disease: Immunogenetics and disease pathogenesis. Gut 2004;53:599-608.
20. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997;113:1675-81.
21. Alric L. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 2000;56:154-8.
22. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998;29:207-13.
23. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis 1998;178:39-44.
24. Fanning LJ, Levis J, Kenny-Walsh E, Wynne F, Whelton M, Shanahan F. Viral clearance in hepatitis C (1b) infection: Relationship with human leukocyte antigen class II in a homogeneous population. Hepatology 2000;31:1334-7.
25. Erlich H, Bugawan T, Begovich A, Scharf S, Griffith R, Saiki R, et al. HLA-DR, DQ and DT typing using PCR amplification and immobilized probes. Eu J Immunogen 1991;18:33-5.
26. Walsh PS, Erlich H, Higuchi R. Preferential PCR amplification of alleles: Mechanisms and solutions. PCR Methods and Applications 1992;1:241-50.
27. Eyster ME, Hatzakis A. HCV genotypes in multitransfused hemophiliacs. Gastroenterology 1996;110:A1187.
28. Stikleryte A, Norder H, Abrutiene J, Magnius LO, Ambrozaitis A. Prevalence of hepatitis C virus (HCV) genotypes in Lithuania. 7th Nordic-Baltic Congress of Infectious Diseases Abstracts. 2006. p. 12.
29. Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Hemophilia 2002; 8(Suppl 2):23-9.
30. Jiao J, Wang JB. Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int 2005;4:80-3.